ALNYLAM PHARMACEUTICALS, INC. Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2017 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Buy | P | 65.35 | 11,500 | 751,502 | 11,500 | 0 to 11.5 K |
| May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 11,000 | 234,850 | 33,994 | |
| May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 75.00 | 11,000 | 825,000 | 10,297 | 21.3 K to 10.3 K (-51.65 %) |
| May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 11,000 | 234,850 | 21,297 | 10.3 K to 21.3 K (+106.83 %) |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 18.66 | 5,625 | 104,963 | 0 | |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 7.10 | 3,750 | 26,625 | 0 | |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 70.00 | 9,375 | 656,250 | 0 | 9.4 K to 0 (-100.00 %) |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 7.10 | 3,750 | 26,625 | 9,375 | 5.6 K to 9.4 K (+66.67 %) |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 18.66 | 5,625 | 104,963 | 5,625 | 0 to 5.6 K |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Option Exercise | M | 31.39 | 32,750 | 1,028,023 | 0 | |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Option Exercise | M | 21.35 | 11,000 | 234,850 | 44,994 | |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Sell | S | 65.00 | 11,000 | 715,000 | 10,297 | 21.3 K to 10.3 K (-51.65 %) |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Buy | M | 21.35 | 11,000 | 234,850 | 21,297 | 10.3 K to 21.3 K (+106.83 %) |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Sell | S | 65.00 | 32,750 | 2,128,750 | 10,297 | 43 K to 10.3 K (-76.08 %) |
| May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Buy | M | 31.39 | 32,750 | 1,028,023 | 43,047 | 10.3 K to 43 K (+318.05 %) |